Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

AUTORISERET FYSIOTERAPEUT ERIK DØSSING ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   11.0% 6.6% 6.2% 6.3% 8.1% 7.0% 14.4% 14.4%   Credit score (0-100)   23 36 36 37 29 35 15 15   Credit rating   BB BBB BBB BBB BB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,333 1,247 1,580 1,831 1,746 1,793 0.0 0.0   EBITDA   670 497 587 782 599 437 0.0 0.0   EBIT   589 443 560 754 566 404 0.0 0.0   Pre-tax profit (PTP)   548.6 411.5 559.4 752.7 567.1 405.7 0.0 0.0   Net earnings   427.4 316.5 436.1 586.2 440.2 313.6 0.0 0.0   Pre-tax profit without non-rec. items   549 411 559 753 567 406 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Tangible assets total   64.4 21.0 5.0 170 145 121 0.0 0.0   Shareholders equity total   148 464 550 702 492 376 15.5 15.5   Interest-bearing liabilities   315 411 355 230 25.8 182 68.1 68.1   Balance sheet total (assets)   986 1,332 1,304 1,371 1,054 927 83.6 83.6   Net Debt   311 409 348 227 -22.4 178 68.1 68.1     See the entire balance sheet 1000.0 Volume  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,333 1,247 1,580 1,831 1,746 1,793 0.0 0.0   Gross profit growth   8.0% -6.5% 26.8% 15.8% -4.6% 2.7% -100.0% 0.0%   Employees   2 2 2 2 3 3 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 50.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   986 1,332 1,304 1,371 1,054 927 84 84   Balance sheet change%   26.8% 35.1% -2.1% 5.2% -23.1% -12.0% -91.0% 0.0%   Added value   669.7 497.4 587.0 782.5 594.1 436.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -162 -108 -53 126 -67 -66 -121 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   44.2% 35.6% 35.5% 41.2% 32.4% 22.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   58.7% 40.8% 45.2% 59.1% 48.1% 42.7% 0.0% 0.0%   ROI %   102.4% 69.1% 65.9% 84.4% 77.9% 74.8% 0.0% 0.0%   ROE %   92.3% 103.4% 86.0% 93.6% 73.8% 72.3% 0.0% 0.0%   1000.0 Solidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Equity ratio %   15.0% 34.4% 42.2% 51.2% 46.7% 40.5% 18.6% 18.6%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   46.5% 82.2% 59.3% 29.0% -3.7% 40.7% 0.0% 0.0%   Gearing %   212.9% 88.6% 64.5% 32.8% 5.2% 48.4% 438.5% 438.5%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   10.2% 17.1% 9.6% 12.8% 12.7% 17.1% 0.0% 0.0%   1000.0 Liquidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Quick Ratio   0.9 1.3 1.6 1.7 1.5 1.3 0.0 0.0   Current Ratio   1.0 1.4 1.7 1.8 1.6 1.5 0.0 0.0   Cash and cash equivalent   3.6 2.4 6.9 3.4 48.2 3.8 0.0 0.0   1000.0 Capital use efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -33.1 336.6 473.6 477.4 308.3 226.5 -34.0 -34.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   335 249 293 391 198 146 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   335 249 293 391 200 146 0 0   EBIT / employee   294 222 280 377 189 135 0 0   Net earnings / employee   214 158 218 293 147 105 0 0